Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1975 1
1996 2
2001 1
2003 1
2004 1
2005 5
2006 3
2007 1
2008 1
2009 3
2010 3
2011 3
2012 5
2013 5
2014 2
2015 4
2016 3
2017 6
2018 5
2019 4
2020 4
2021 6
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jjm. Clin Cancer Res. 2017 Aug 15;23(16):4617-4624. doi: 10.1158/1078-0432.CCR-16-2743. Epub 2017 Apr 20. Clin Cancer Res. 2017. PMID: 28428192
Clinical Pharmacology of Radiotheranostics in Oncology.
Te Beek ET, Burggraaf J, Teunissen JJM, Vriens D. Te Beek ET, et al. Among authors: teunissen jjm. Clin Pharmacol Ther. 2022 Apr 3. doi: 10.1002/cpt.2598. Online ahead of print. Clin Pharmacol Ther. 2022. PMID: 35373336 Review.
Peptide receptor radionuclide therapy of neuroendocrine tumours.
Brabander T, Teunissen JJ, Van Eijck CH, Franssen GJ, Feelders RA, de Herder WW, Kwekkeboom DJ. Brabander T, et al. Among authors: teunissen jj. Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):103-14. doi: 10.1016/j.beem.2015.10.005. Epub 2015 Oct 8. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971847 Review.
Nuclear Medicine Imaging of Neuroendocrine Tumors.
Brabander T, Kwekkeboom DJ, Feelders RA, Brouwers AH, Teunissen JJ. Brabander T, et al. Among authors: teunissen jj. Front Horm Res. 2015;44:73-87. doi: 10.1159/000382059. Epub 2015 Aug 14. Front Horm Res. 2015. PMID: 26303705 Review.
Lutetium-labelled peptides for therapy of neuroendocrine tumours.
Kam BL, Teunissen JJ, Krenning EP, de Herder WW, Khan S, van Vliet EI, Kwekkeboom DJ. Kam BL, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1(Suppl 1):S103-12. doi: 10.1007/s00259-011-2039-y. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388631 Free PMC article. Review.
Precision medicine and theranostics using radiopharmaceuticals in oncology.
Te Beek ET, Teunissen JJM, Postema JWA, Lafeber A, Ten Broek MRJ. Te Beek ET, et al. Among authors: teunissen jjm. Br J Clin Pharmacol. 2022 Jan;88(1):359-361. doi: 10.1111/bcp.14942. Epub 2021 Jun 22. Br J Clin Pharmacol. 2022. PMID: 34159632 No abstract available.
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: teunissen jj. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11. doi: 10.1007/s00259-016-3382-9. Epub 2016 May 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 27160225 Free PMC article.
72 results